Skip to main content

New resources available to accelerate the adoption of novel digital clinical measures in clinical research

Take the fast track to becoming a V3 and V3+ expert

Service Médical Rendu (SMR)

/ˈsɜːvɪs ɛmédical Rendu (ɛs-ɛm-ɑː)/

The benefit set by the French Haute Autorité de Santé (HAS) is a criterion which takes into account: the seriousness of the pathology for which the medicine is indicated; and the data specific to the drug itself in a given indication.